Pefloxacin Mesylate Production Cost Reports

The report provides a detailed analysis essential for establishing a Pefloxacin Mesylate production plant. It encompasses all critical aspects necessary for Pefloxacin Mesylate production, including the cost of Pefloxacin Mesylate production, Pefloxacin Mesylate plant cost, Pefloxacin Mesylate production costs, and the overall Pefloxacin Mesylate production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Pefloxacin Mesylate production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Pefloxacin Mesylate is a fluoroquinolone antibiotic salt, utilised in pharmaceutical production to produce formulations targeting bacterial infections such as urinary tract, respiratory, and gastrointestinal conditions in humans and veterinary medicine. Its specialised formulations include liposome combinations for injections, oral preparations, sprays, suppositories, and freeze-dried powders.

These utilise advanced techniques such as ultrafiltration-spray drying and high-pressure homogenisation to deliver broad-spectrum antibacterial efficacy against both Gram-positive and Gram-negative pathogens. It is also used in industrial labs for analytical methods such as colourimetric assays and HPLC for quality control, detection in biological/food samples, and research into resistance challenges.

The market growth for pefloxacin mesylate is propelled by the rising prevalence of bacterial infections, mainly urinary tract, respiratory, and gastrointestinal conditions in developing regions with limited healthcare access. Additionally, increasing antibiotic resistance sustains demand for its broad-spectrum efficacy. Its cost-effectiveness compared to newer antibiotics and expanding veterinary applications boosts the market growth.

Moreover, ongoing R&D for enhanced formulations like liposomes and combinations to improve bioavailability and counter resistance, supported by government incentives for pharmaceutical innovation, fuels market expansion. Industrial pefloxacin mesylate procurement is influenced by pricing volatility, arising from raw material costs of key intermediates like 2,4-dichloro-5-fluoro-benzoyl chloride, currency exchange rates, and negotiated MOQs amid global supply gluts or shortages.

Raw Material for Pefloxacin Mesylate Production

According to the Pefloxacin Mesylate production plant project report, the various raw materials for Pefloxacin Mesylate production include norfloxacin and solid formaldehyde.

Production Process of Pefloxacin Mesylate

The extensive Pefloxacin Mesylate production cost report consists of the following major industrial production process:

1. Production via N methylation: The production process of pefloxacin mesylate starts from norfloxacin by using solid formaldehyde to perform an N methylation, followed directly by salt formation with methanesulfonic acid, avoiding isolation of the intermediate. In this route, solid paraformaldehyde, 85% formic acid, and norfloxacin are charged to a reactor, and the slurry is gradually heated to reflux (70-95 degree Celsius) for several hours to complete the methylation. In the next step, the residual formic acid and formaldehyde are removed under reduced pressure with repeated water co distillation. After solvent exchange into about 83% aqueous ethanol, methanesulfonic acid is added and the mixture is heated to 70-75 degree Celsius for the salt forming step, followed by cooling to 0-5 degree Celsius to crystallise pefloxacin mesylate dihydrate. Finally, the compound is filtered and dried, followed by activated carbon treatment and recrystallisation from 83% ethanol.

Properties of Pefloxacin Mesylate

Pefloxacin Mesylate (C18H24FN3O6S, molecular weight 429.46 g/mol), commonly as the dihydrate, is an off-white to pale beige crystalline powder with purity >99%. It has free solubility in water (61 mg/mL), slight solubility in ethanol, and insolubility in many organic solvents, along with a relative density of 1.32 g/cm³. This fluoroquinolone mesylate salt acts as a broad-spectrum antibacterial by inhibiting DNA gyrase, featuring LC-MS fragments at m/z 334.16 (100%) and 290.17, with collision cross-sections of 176.1-187 Ų. It requires stable storage at -20 degree Celsius (solid) or -80 degree Celsius (solution) to prevent degradation, and maintains integrity under 2-8 degree Celsius cold chain conditions during handling.